Mortality risk of antidiabetic agents for type 2 diabetes with COVID-19: a systematic review and meta-analysis
C Kan, Y Zhang, F Han, Q Xu, T Ye, N Hou… - Frontiers in …, 2021 - frontiersin.org
… Accordingly, we conducted a systemic review and meta-analysis to investigate the
associations of antidiabetic agents with mortality in patients with T2DM who have COVID-19. …
associations of antidiabetic agents with mortality in patients with T2DM who have COVID-19. …
Commentary: mortality risk of antidiabetic agents for type 2 diabetes with COVID-19: a systematic review and meta-analysis
LM Zhao, XH Chen, M Qiu - Frontiers in Endocrinology, 2022 - frontiersin.org
… use of four kinds of hypoglycemic agents (ie, metformin, … and risk of COVID-19 mortality
in patients with type 2 diabetes … various hypoglycemic agents in COVID-19 death risk, and …
in patients with type 2 diabetes … various hypoglycemic agents in COVID-19 death risk, and …
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
… In this systematic review and meta-analysis, we (1) summarized the effects of every single
antidiabetic medication on the mortality of patients with COVID-19 having diabetes and (2) …
antidiabetic medication on the mortality of patients with COVID-19 having diabetes and (2) …
Use of novel antidiabetic agents in patients with type 2 diabetes and COVID-19: a critical review
DS Popovic, N Papanas, A Pantea Stoian, AA Rizvi… - Diabetes Therapy, 2021 - Springer
… severe forms of COVID-19 that lead to increased mortality. The use of novel antidiabetic
agents dipeptidyl peptidase 4 inhibitors (DPP4i), sodium-glucose co-transporter 2 inhibitors (…
agents dipeptidyl peptidase 4 inhibitors (DPP4i), sodium-glucose co-transporter 2 inhibitors (…
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review
AK Singh, K Khunti - Diabetes research and clinical practice, 2020 - Elsevier
… to review the risk, severity and mortality in COVID-19 and its … , and role of anti-diabetic agents
in patients with diabetes. … nationwide diabetes prevalence of around 11% of type 2 diabetes …
in patients with diabetes. … nationwide diabetes prevalence of around 11% of type 2 diabetes …
Association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis
T Han, S Ma, C Sun, H Zhang, G Qu, Y Chen… - Archives of medical …, 2022 - Elsevier
… diabetes and COVID-19 showed that metformin was not … significant reduced mortality risk
in patients with only type 2 diabetes (… mortality risk or poor composite outcomes of COVID-19 …
in patients with only type 2 diabetes (… mortality risk or poor composite outcomes of COVID-19 …
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: a critical appraisal of literature
AK Singh, R Singh, B Saboo, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
… literature review, we sought to evaluate the outcomes with non-insulin anti-diabetes agents
in patients of T2DM with COVID-19… study found a 56% relative decrease in all-cause mortality …
in patients of T2DM with COVID-19… study found a 56% relative decrease in all-cause mortality …
Effect of antidiabetic therapy on clinical outcomes of COVID-19 patients with type 2 diabetes: a systematic review and meta-analysis
K Zhan, L Weng, L Qi, L Wang, H Lin… - Annals of …, 2023 - journals.sagepub.com
… the risk of mortality and ICU admission among COVID-19 … In summary, this systematic review
and meta-analysis … a range of antidiabetic drugs in the management of COVID-19 patients …
and meta-analysis … a range of antidiabetic drugs in the management of COVID-19 patients …
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
D Gonikman, D Kustovs - Medicina, 2023 - mdpi.com
… that diabetes is a major risk factor for a severe COVID-19 … of anti-diabetic drugs, their efficacy
in decreasing mortality rates… treatment of COVID-19 patients with type 2 diabetes mellitus (…
in decreasing mortality rates… treatment of COVID-19 patients with type 2 diabetes mellitus (…
The association between antidiabetic agents and clinical outcomes of COVID-19 patients with diabetes: a Bayesian network meta-analysis
Y Chen, X Lv, S Lin, M Arshad, M Dai - Frontiers in Endocrinology, 2022 - frontiersin.org
… the following: (1) reviews, systematic reviews, correspondences, or in … -analysis on these
seven antidiabetic agents to compare COVID-19 mortality between different antidiabetic agents, …
seven antidiabetic agents to compare COVID-19 mortality between different antidiabetic agents, …